CN107865944A - A kind of clarification process and method of quality control with the pharmaceutical composition for repairing skin barrier effect - Google Patents
A kind of clarification process and method of quality control with the pharmaceutical composition for repairing skin barrier effect Download PDFInfo
- Publication number
- CN107865944A CN107865944A CN201710885659.3A CN201710885659A CN107865944A CN 107865944 A CN107865944 A CN 107865944A CN 201710885659 A CN201710885659 A CN 201710885659A CN 107865944 A CN107865944 A CN 107865944A
- Authority
- CN
- China
- Prior art keywords
- pharmaceutical composition
- solution
- skin barrier
- medicinal material
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 73
- 230000008591 skin barrier function Effects 0.000 title claims abstract description 38
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 37
- 230000000694 effects Effects 0.000 title claims abstract description 33
- 238000005352 clarification Methods 0.000 title claims abstract description 31
- 230000008569 process Effects 0.000 title claims abstract description 24
- 238000003908 quality control method Methods 0.000 title claims abstract description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 70
- 239000003814 drug Substances 0.000 claims abstract description 51
- 239000000463 material Substances 0.000 claims abstract description 40
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 33
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 30
- 239000000203 mixture Substances 0.000 claims abstract description 26
- 238000004587 chromatography analysis Methods 0.000 claims abstract description 17
- 229930182470 glycoside Natural products 0.000 claims abstract description 17
- 150000002338 glycosides Chemical class 0.000 claims abstract description 17
- 239000008395 clarifying agent Substances 0.000 claims abstract description 16
- 241000934230 Anoectochilus roxburghii Species 0.000 claims abstract description 15
- 241001106412 Pilea Species 0.000 claims abstract description 14
- 241000719837 Anoectochilus Species 0.000 claims abstract description 11
- RHJULGLSOARXMO-YXRGHUGASA-N Camellianin A Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](OC=2C=3C(=O)C=C(OC=3C=C(O)C=2)C=2C=CC(O)=CC=2)O[C@@H]1COC(C)=O RHJULGLSOARXMO-YXRGHUGASA-N 0.000 claims abstract description 11
- HYQNKKAJVPMBDR-HIFRSBDPSA-N Hernandulcin Chemical compound CC(C)=CCC[C@](C)(O)[C@@H]1CCC(C)=CC1=O HYQNKKAJVPMBDR-HIFRSBDPSA-N 0.000 claims abstract description 11
- HYQNKKAJVPMBDR-UHFFFAOYSA-N Hernandulcin Natural products CC(C)=CCCC(C)(O)C1CCC(C)=CC1=O HYQNKKAJVPMBDR-UHFFFAOYSA-N 0.000 claims abstract description 11
- RHJULGLSOARXMO-UHFFFAOYSA-N camellianin A Natural products OC1C(O)C(O)C(C)OC1OC1C(O)C(O)C(OC=2C=3C(=O)C=C(OC=3C=C(O)C=2)C=2C=CC(O)=CC=2)OC1COC(C)=O RHJULGLSOARXMO-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000004575 stone Substances 0.000 claims abstract description 11
- VZRKWGPIZJDNHC-LUNVCWBOSA-N Polygalic acid Polymers CC1(C)CC[C@@]2(CCC3=C(CC[C@@H]4[C@@]5(C)C[C@H](O)[C@H](O)[C@](C)([C@@H]5CC[C@@]34C)C(O)=O)[C@@H]2C1)C(O)=O VZRKWGPIZJDNHC-LUNVCWBOSA-N 0.000 claims abstract description 10
- VZRKWGPIZJDNHC-UHFFFAOYSA-N Polygalic acid Natural products CC1(C)CCC2(CCC3=C(CCC4C5(C)CC(O)C(O)C(C)(C5CCC34C)C(O)=O)C2C1)C(O)=O VZRKWGPIZJDNHC-UHFFFAOYSA-N 0.000 claims abstract description 10
- 241000146384 Glaux Species 0.000 claims abstract description 9
- 239000000284 extract Substances 0.000 claims abstract description 9
- 238000004811 liquid chromatography Methods 0.000 claims abstract description 3
- 241000218628 Ginkgo Species 0.000 claims abstract 9
- 244000269722 Thea sinensis Species 0.000 claims abstract 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 105
- 239000000243 solution Substances 0.000 claims description 64
- 238000002360 preparation method Methods 0.000 claims description 39
- 238000012360 testing method Methods 0.000 claims description 25
- 239000000523 sample Substances 0.000 claims description 23
- 239000007788 liquid Substances 0.000 claims description 22
- 150000001875 compounds Chemical class 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 239000013558 reference substance Substances 0.000 claims description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 12
- 239000012141 concentrate Substances 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 12
- 230000008439 repair process Effects 0.000 claims description 11
- 239000007787 solid Substances 0.000 claims description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 10
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 10
- 239000000047 product Substances 0.000 claims description 10
- 238000010828 elution Methods 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- 238000002137 ultrasound extraction Methods 0.000 claims description 9
- 238000001514 detection method Methods 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 239000011347 resin Substances 0.000 claims description 8
- 229920005989 resin Polymers 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 238000001179 sorption measurement Methods 0.000 claims description 8
- 150000004676 glycans Chemical class 0.000 claims description 7
- 229920001282 polysaccharide Polymers 0.000 claims description 7
- 239000005017 polysaccharide Substances 0.000 claims description 7
- 239000007921 spray Substances 0.000 claims description 7
- 229920000297 Rayon Polymers 0.000 claims description 6
- 238000010790 dilution Methods 0.000 claims description 6
- 239000012895 dilution Substances 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 239000003480 eluent Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 239000012535 impurity Substances 0.000 claims description 6
- 239000007791 liquid phase Substances 0.000 claims description 6
- 235000011837 pasties Nutrition 0.000 claims description 6
- 239000000741 silica gel Substances 0.000 claims description 6
- 229910002027 silica gel Inorganic materials 0.000 claims description 6
- KIBLEPZGKRYXBB-UHFFFAOYSA-N butan-2-one ethyl acetate formic acid hydrate Chemical compound O.OC=O.CCC(C)=O.CCOC(C)=O KIBLEPZGKRYXBB-UHFFFAOYSA-N 0.000 claims description 5
- 238000011067 equilibration Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- DOAOYJIOTYDTNV-UHFFFAOYSA-N butan-1-ol;ethyl acetate;hydrate Chemical compound O.CCCCO.CCOC(C)=O DOAOYJIOTYDTNV-UHFFFAOYSA-N 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 239000004382 Amylase Substances 0.000 claims description 3
- 102000013142 Amylases Human genes 0.000 claims description 3
- 108010065511 Amylases Proteins 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 235000019418 amylase Nutrition 0.000 claims description 3
- 238000011161 development Methods 0.000 claims description 3
- 238000012417 linear regression Methods 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 230000004044 response Effects 0.000 claims description 3
- 239000012488 sample solution Substances 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 230000001112 coagulating effect Effects 0.000 claims description 2
- 239000000945 filler Substances 0.000 claims description 2
- 235000019253 formic acid Nutrition 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 2
- 239000000377 silicon dioxide Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 239000003643 water by type Substances 0.000 claims description 2
- CUXSAAMWQXNZQW-UHFFFAOYSA-N acetic acid;butan-1-ol Chemical compound CC(O)=O.CCCCO CUXSAAMWQXNZQW-UHFFFAOYSA-N 0.000 claims 1
- 230000004888 barrier function Effects 0.000 claims 1
- 238000003556 assay Methods 0.000 abstract description 6
- 230000007547 defect Effects 0.000 abstract 1
- 238000000151 deposition Methods 0.000 abstract 1
- 238000011017 operating method Methods 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 244000194101 Ginkgo biloba Species 0.000 description 24
- 241001122767 Theaceae Species 0.000 description 13
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 8
- 239000006025 fining agent Substances 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 230000014759 maintenance of location Effects 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 150000003431 steroids Chemical class 0.000 description 4
- 235000007516 Chrysanthemum Nutrition 0.000 description 3
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 240000002853 Nelumbo nucifera Species 0.000 description 3
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 3
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 3
- 241000208966 Polygala Species 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- -1 terpene lactones Chemical class 0.000 description 3
- 241000208327 Apocynaceae Species 0.000 description 2
- 241000218791 Ginkgoaceae Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000233855 Orchidaceae Species 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 2
- 241001529246 Platymiscium Species 0.000 description 2
- 240000004980 Rheum officinale Species 0.000 description 2
- 235000008081 Rheum officinale Nutrition 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000005189 flocculation Methods 0.000 description 2
- 230000016615 flocculation Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- SWVXQNMTYWWRJN-CYDGBPFRSA-N (4S)-5-[[(2S)-1-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-[[2-[[(2S)-2-aminopropanoyl]amino]acetyl]amino]-5-oxopentanoic acid Chemical compound CC(C)C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](C)N)C(=O)N[C@@H](CO)C(N)=O SWVXQNMTYWWRJN-CYDGBPFRSA-N 0.000 description 1
- AJLNZWYOJAWBCR-OOPVGHQCSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=C)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O AJLNZWYOJAWBCR-OOPVGHQCSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 241001438349 Adinandra nitida Species 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 241000609218 Amsonia elliptica Species 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 244000080767 Areca catechu Species 0.000 description 1
- 235000006226 Areca catechu Nutrition 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 244000157790 Buglossoides arvense Species 0.000 description 1
- 235000004256 Buglossoides arvense Nutrition 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241000270722 Crocodylidae Species 0.000 description 1
- 240000004784 Cymbopogon citratus Species 0.000 description 1
- 235000017897 Cymbopogon citratus Nutrition 0.000 description 1
- 240000004638 Dendrobium nobile Species 0.000 description 1
- 241000522190 Desmodium Species 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 208000007027 Oral Candidiasis Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 240000004064 Poterium sanguisorba Species 0.000 description 1
- 235000008291 Poterium sanguisorba Nutrition 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 244000153955 Reynoutria sachalinensis Species 0.000 description 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010049677 Salpingo-oophoritis Diseases 0.000 description 1
- 241000612118 Samolus valerandi Species 0.000 description 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 description 1
- 240000003705 Senecio vulgaris Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010042170 Strangury Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 241000205578 Thalictrum Species 0.000 description 1
- 241000287411 Turdidae Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 240000001519 Verbena officinalis Species 0.000 description 1
- 235000018718 Verbena officinalis Nutrition 0.000 description 1
- 241000107739 Vincetoxicum versicolor Species 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- XBJFCYDKBDVADW-UHFFFAOYSA-N acetonitrile;formic acid Chemical compound CC#N.OC=O XBJFCYDKBDVADW-UHFFFAOYSA-N 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 238000001246 colloidal dispersion Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- LNNWVNGFPYWNQE-GMIGKAJZSA-N desomorphine Chemical compound C1C2=CC=C(O)C3=C2[C@]24CCN(C)[C@H]1[C@@H]2CCC[C@@H]4O3 LNNWVNGFPYWNQE-GMIGKAJZSA-N 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000003061 neural cell Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical class CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229930182493 triterpene saponin Natural products 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/90—Plate chromatography, e.g. thin layer or paper chromatography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of clarification process and method of quality control of the pharmaceutical composition for having and repairing skin barrier effect,The medicine is by radix cynanchi atrati,Pilea fasciata,Ginkgo leaf,False-yellowflower milkwort root or herb,Stone precipice tea and the taste medicinal material of roxburgh anoectochilus terminal bud 6 composition,Specific clarification process is to clarify pharmaceutical composition extract solution with II type ZTC 1+1 natural clarifying agents,Specific method of quality control is to radix cynanchi atrati in pharmaceutical composition with thin-layered chromatography,Ginkgo leaf carries out thin layer discriminating,In combination with high effective liquid chromatography for measuring pharmaceutical composition Hernandulcin,Polygalic acid,The content of camellianin A and anoectochilus roxburghii glycosides,The clarification process and method of quality control that the present invention uses,It is few with equipment investment,Operating procedure is simple,It is big to overcome traditional alcohol deposition method consumption alcohol amount,Ethanol recovery is cumbersome,The defects of medicine multicomponent complicated assay method,Quickly,Effectively ensure that the inherent quality of composition,Curative effect and stability,Improve the controllability of pharmaceutical composition quality standard.
Description
Technical field
The present invention detects technical field of traditional Chinese medicine preparation using the clarification process and day analytical instrumentation of natural clarifying agent,
It is related to a kind of method of quality control for the pharmaceutical composition for repairing skin barrier.
Background technology
In recent years, widely using with glucocorticoid external preparation, steroid dependent dermatitis gradually increases, it has also become
The common disease of dept. of dermatology.The disease has polymorphic infringement, to hormone dependant, the features such as recurrent exerbation, drastically influence patient's
Appearance and mental health.In general, potent hormone ointment uses more than 1.5 months in face, weak to imitate or swash containing micro
The violation cosmetics of element use (1-2) for a long time, all can locally induce steroid dependent dermatitis.Long-term external application sugar cortical hormone
Element causes Skin barrier destruction, and atrophy occurs in skin, and cuticula is thinning, papilla regression, while inflammation inducing factor expression
It is relevant, make skin of face inflammation recurrent exerbation and gradually aggravate, so as to produce dependence to hormone.Patient skin barrier function destroys
Afterwards, skin increases to the sensitiveness of extraneous various physicochemical irritations, the symptom after Exposure to Sunlight, wind, heat and feed irritable food
Aggravate.Therefore, anti-anaphylaxis, the moisturizing medical science skin care item that can recover skin barrier function should be used cooperatively, to reduce cutaneous sensibility.
For this case, emphasis of many researchers using skin repair product as research and development.Such as patent 201510725856.X, this is special
Profit discloses a kind of skin repair liquid and its application, and the skin repair liquid includes glycerine, 1,2- pentanediols, dipotassium glycyrrhizinate, people
Oligopeptides, Sodium Hyaluronate, aloe barbadensis Miller juice, water.Such as patent 201510888998.8, a kind of skin which disclose
Liquid and preparation method thereof is repaired, the reparation liquid is by safflower, Herba portulacae, rheum officinale, folium artemisiae argyi, rhizoma Gastrodiae, rice vinegar, lemongrass, lemon, crocodile egg
Stoste forms.Such as patent 201510540856.2, the patent discloses a kind of peptide composition for skin repair, the polypeptide by
Hexapeptide -3, copper peptide, palmityl tripeptides -1, pentapeptide -31 etc. form.Such as patent 201510812038.3, one kind which disclose
For the formulation preparation method and its preparation of skin repair, said preparation is by rheum officinale, borneol, Asian puccoon, garden burnet, giant knotweed, kuh-seng, awns
Nitre, the root of Dahurain angelica, Verbena officinalis, desmodium, climbing groundsel, ginkgo leaf, the stem of noble dendrobium, pearl, catechu, rhizoma atractylodis, honeysuckle etc. form.But these are produced
Product are not all started with from the pathologic, physiologic feature of steroid dependent dermatitis to be solved the problems, such as, therefore usage time is grown, and effect is but paid no attention to
To think, this just brings puzzlement for manufacturer and user, and many chemicals can cause irreversible injury to skin,
And natural plants cosmetics to no skin irritation, and can help skin gradually to recover normal function without using chemicals,
Therefore natural plants cosmetics enjoy consumers.
The preparation of compound Chinese medicinal preparation often includes extraction process, and obtained Chinese medical extract is a complicated mixing
System, including active component and impurity, wherein (even containing materials such as substantial amounts of minuteness particle, starch, tannin, protein, polysaccharide
Have the impurity such as medicinal material residue, silt), it is colloidal dispersion system to be collectively forming 1-100Knm, belongs to dynamics and thermodynamics is unstable
Determine system, the trend with spontaneous sedimentation.For retentive activity composition, these impurity are removed, makes solid-liquid rapid and is completely separated from,
The stability of destruction mixed system will be tried.Compound Chinese medicinal preparation uses aqueous extraction-alcohol precipitation technology more, and the technique has clarification medicine
Liquid, reduce the advantages that dose.But the technique is in clarification decoction simultaneously by the macromolecular of some alcohol insoluble matters in Chinese medicine such as egg
White matter and par-tial polysaccharide remove as impurity, and these compositions have extensive physiologically active and medical value.Clarificant method
It is to add a kind of fining agent in the Chinese medicine extract of suspension to remove corase particles in solution in a manner of adsorption bridging and charge neutrality,
To reach a kind of high efficiency technical for isolating and purifying purpose, ZTC1+1 natural clarifying agents are that one kind is extracted from food, with natural more
Sugar etc. is natural high molecular substance made of raw material, is made up of A, B2 kind component, and it is using " 1+1 " clarification skill that it, which clarifies principle,
Art, wherein 1 component plays main flocculation, another 1 component plays auxiliary flocculation, has preferable clarifying effect.
With the reach of science, the popularization and application of analytical instrument, Chinese medicine compound prescription detection and analysis and quality control is set constantly to carry
It is high and perfect.Thin layerChromatogramMethod (TLC), being will be suitableStationary phaseIt is coated on glass plate, plastics or aluminium substrate, it is uniform into one
Thin layer.After point sample, expansion, according toRf value(Rf) with the Rf value (Rf) of the suitable tester chromatogram of gained by the same method
Compare, be quick separating and a small amount of thing of qualitative analysis to carry out the discriminating of medicine, determination of foreign matter or the method for assay
A kind of critically important experimental technique of matter, it is also used for tracking reaction process.High performance liquid chromatography detection analytical technology is in Chinese medicine matter
Played an increasingly important role in amount control.It is that Chinese medicine or compound are carried out into go-on-go by analysis means such as spectral chromatographies
Survey, utilize the distinctive chemical profile of heterogeneity, the species and content of the intrinsic chemical composition contained by reflection Chinese medicine or compound.
Pharmaceutical composition is by radix cynanchi atrati, Pilea fasciata, ginkgo leaf, false-yellowflower milkwort root or herb, stone precipice tea and the taste medicinal material of roxburgh anoectochilus terminal bud 6
Composition, its active component is more, according to 2015 editions Chinese Pharmacopoeias, chromatographic condition and the system suitability side of each component medicinal material
Method is different, determines the target component content of each medicinal material in compound one by one, is unfavorable for evaluating and controls the quality of herbal mixture,
So as to ensure the stability of its effective component and quantity.
The present invention from substantial amounts of natural drug, has selected radix cynanchi atrati, Pilea fasciata, ginkgo leaf, Huang according to tcm theory
Flower omei meadowrue herb, stone precipice tea and roxburgh anoectochilus terminal bud are raw material, prepare and clarify the composition for obtaining described reparation skin barrier, its
In, described radix cynanchi atrati selects the dry root of Asclepiadaceae plant radix cynanchi atrati；Pilea fasciata selects Urticaceae Pilea；Bastard cold water
Colored drying herb；Ginkgo leaf selects the dried leaf of Ginkgoaceae plant Ginkgo biloba；False-yellowflower milkwort root or herb selects Polygalaceae polygala
The dry root of false-yellowflower milkwort root or herb；Roxburgh anoectochilus terminal bud selects the drying herb of orchidaceae is a perennial herb roxburgh anoectochilus terminal bud；Stone precipice tea
It is fragrant through Guangdong Provincial TCM Hospital Pharmaceutical Department Chen Yan from the yellow auspicious wooden dried leaf of the bright leaf of Theaceae Yang Tong platymisciums, the above-mentioned prepared slices of Chinese crude drugs
Director pharmacist of traditional Chinese medicine identification meets national standard, and it is for future reference that sample voucher is deposited in Guangdong Provincial TCM Hospital Chinese medicine preparation laboratory.
According to《Chinese Pharmacopoeia》Recorded with document：
Radix cynanchi atrati is radix cynanchi atrati from Asclepiadaceae plant radix cynanchi atrati or the dry root or rhizome of Cynanchum versicolor Bunge.Radix cynanchi atrati is bitter, salty, cold, returns
Stomach, liver and kidney channel, function clearing heat and cooling blood, inducing diuresis for treating strangurtia, detoxification sore treatment.For the heating of warm evil wound battalion, fever due to yin deficiency, hectic fever due to yin labor it is hot,
Postpartum fever caused by blood deficiency, heat gonorrhea, blood strangury, swollen ulcer drug.
Pilea fasciata also known as fasciate clearweed herb, blue or green medicine, common clearweed herb, amsonia elliptica, anise, palace fiber crops, are Urticaceae Pilea
The herb of Pilea fasciata, the province such as China Guangxi, Guizhou, Sichuan and Yunnan is distributed in, there is clearing heat and detoxicating, promoting blood circulation by removing wind, reason
The effect of gas relieves pain, cures mainly high fever, tonsillitis swelling and pain, thrush, traumatic injury, fracture, arthralgia pain due to rheumatism, Guangxi it is among the people with it in being good for
Spleen, lactagogue, cough-relieving, anti-inflammatory, preventing and treating adnexitis and gynecopathy such as pelvic inflammatory disease.
Ginkgo leaf is the dried leaf of Ginkgoaceae plant Ginkgo biloba.Ginkgo leaf is a kind of rare Chinese medicine, sweet, bitter, puckery, flat, is returned
The heart, lung channel.Function is promoting blood circulation and removing blood stasis, removes obstruction in channels to relieve pain, astringes the lung and relieving asthma, change turbid lipid-loweringing, for treat obstruction of collaterals by blood stasis, chest impediment and cardialgia, in
Windage yaw paralysis, deficiency syndrome of the lung cough and asthma, hyperlipidemia.Research thinks that the main active in ginkgo leaf has flavonoids, terpene lactones at present
Class, organic acid, additionally containing polypenthylene alcohols ester, polysaccharide, alkyl phenolic acid compound and some other nutritional ingredients
Deng.Ginkgo biloba p.e has the function that to mitigate neural cell injury and cerebral ischemic.
False-yellowflower milkwort root or herb also known as chrysanthemum ginseng, chrysanthemum hang water lotus, and it is the drying of Polygalaceae polygala false-yellowflower milkwort root or herb
Root, it is a kind of long folk medicine of applicating history.It has invigorating the spleen, dissipate blood stasis and smoothing collaterals and other effects, is conventionally used to treat overstrain
Under the weak, prolapse of uterus, infantile malnutrition, edema due to deficiency of the spleen, band, the disease such as irregular menstruation, traumatic injury, acute, chronic hepatitis.Newest
Research finds that it has good antioxidant radical activity, and its saponin component has very strong effect for reducing blood fat.
Stone precipice tea is the yellow auspicious wooden dried leaf of the bright leaf of Theaceae Yang Tong platymisciums, also known as clint tea, Shi Yancha, tor tea,
Red light, the bright yellow auspicious wood of leaf of Adinandra nitida, bright leaf, is distributed mainly on the ground such as China Guangxi, Guangdong and Guizhou, aboundresources is among the people
Using the with a long history of the plant.Stone precipice tea gives off a strong fragrance, the then sweet cool sweetness of taste elder generation slight bitter, have it is clearing heat and detoxicating, protect liver is bright
Mesh, anti-inflammatory moistening lung, beauty treatment decompression, Adjust-blood lipid, stomach strengthening and digestion promoting etc. act on, and are all very high wild plants of a kind of health care and medical value
Thing.The compositions such as flavonoids, triterpene saponin, Tea Polyphenols, polysaccharide are mainly contained in the tea of stone precipice.
Roxburgh anoectochilus terminal bud is orchidaceae is a perennial herb roxburgh anoectochilus terminal bud, is very rare Chinese herbal medicine, is known as " god
The laudatory titles such as grass " " black ginseng ".Whole body is medicinal, and taste is put down, and property is sweet, has clearing heat and cooling blood, removing dampness and detoxicating, the function such as prolong life, can
Treat cough with lung heat, treating rheumatic ostealgia, diabetes, cystitis etc..Rich in polysaccharide, flavonoids, trace element, amino acid, phenols, three
The many kinds of substance such as terpene.
At present, both at home and abroad there is not yet radix cynanchi atrati, Pilea fasciata, ginkgo leaf, false-yellowflower milkwort root or herb, stone precipice tea and roxburgh anoectochilus terminal bud are carried
The composition of thing is taken to be used for the relevant report for repairing skin barrier.
Compared with prior art, the beneficial effects of the invention are as follows：Pharmaceutical composition provided by the invention, for the knot of skin
Structure and the mechanism of steroid dependent dermatitis skin damage, have the work for improving epidermal cell microcirculation and promoting skin metabolism
With, can accelerate regeneration with repair etc. effect；The clinical trial of scientific and precise further proves that it has good reparation skin
Skin barrier action, and without skin irritation, adverse reaction is low, fool proof, and social required quantity is big, is especially suitable for being added to cream
In the cosmetics such as emulsion, there is good social and economic benefit.
The content of the invention
Present invention aims at according to modern technologies, there is provided a kind of to have the Chinese medicine combination for repairing skin barrier effect
The High-speed clarification of thing, efficient method of quality control, drug regimen amount of substance is evaluated and controlled on the whole, ensure to repair skin screen
The effect of hindering Chinese medicine is more stable, reliable.
The present invention is to be achieved through the following technical solutions：
A kind of clarification process with the pharmaceutical composition for repairing skin barrier effect, take with reparation skin barrier effect
Chinese medicine preparation conventional ethanol soak extraction, soak is concentrated under reduced pressure, concentrate macroporous resin adsorption, 5%-95% ethanol
Elution, eluent concentration, as described has the pharmaceutical composition for repairing skin barrier effect, is placed in 60 DEG C of water-baths, first adds
Enter the II type ZTC1+1 natural clarifying agent B components of 4% effluent volume, the II types ZTC1+1 that 2% volume is added after 1h is naturally clear
Clear agent component A, during which stirred 1 minute per half an hour and make impurity component coagulative precipitation, then with 4000r/min in centrifuge
10min is centrifuged, takes supernatant；Described II type ZTC1+1 natural clarifying agents：It is one kind using natural polysaccharide as made of raw material
Natural high molecular substance, it is made up of two components of A, B, component A is yellowish-brown soluble solids powder or light brown liquid, mainly
Amylase-containing, it is made into 1% aqueous solution use；B component is light yellow soluble solids powder or light brown liquid, mainly containing shallow lake
The complex enzyme of powder enzyme, the solution that 1% concentration is made into 1% acetic acid use.
Component A, precision measure 1.0g II type ZTC1+1 natural clarifying agents and added on a small quantity in distilled water, stir into pasty state, then
The viscose that distilled water is formulated into 100mL is added, 24h is swelled, is filtered with double gauze；
B component, it is molten that precision measures the acetic acid that a small amount of volume fraction of 1.0g II type ZTC1+1 natural clarifying agents addition is 1%
Liquid, pasty state is stirred into, then the acetum for adding volume fraction to be 1% is configured to 100mL viscose, 24h is swelled, with double-deck yarn
Cloth filters..
A kind of clarification process and method of quality control with the pharmaceutical composition for repairing skin barrier effect, its feature exist
In this method comprises the following steps：
(1) the medicine Chinese medicine radix cynanchi atrati is differentiated with thin-layered chromatography, including：
A. the preparation of test sample：This product pharmaceutical composition 2mL is taken, adds methanol 30mL, ultrasonic extraction 20 minutes, filters,
Filtrate is evaporated, and residue adds methanol 1mL to make dissolving, as need testing solution；
B. the preparation of control medicinal material solution：Radix cynanchi atrati control medicinal material powder 1g is taken, adds methanol 30mL, ultrasonic extraction 20 minutes,
Filtration, filtrate are evaporated, and residue adds methanol 1mL to make dissolving, as radix cynanchi atrati medicinal material solution；
C. radix cynanchi atrati indentification by TLC：Tested according to thin-layered chromatography, draw control medicinal material solution and sample solution each 2 respectively
μ L, put respectively on same silica gel g thin-layer plate, using n-butanol-ethyl acetate-water (4: 1: 5) as solvent, deploy, take out,
Dry, spray ethanol solution of sulfuric acid, it is clear to be heated to spot development at 105 DEG C, is inspected under white light；
(2) the medicine Chinese medicine ginkgo leaf is differentiated with thin-layered chromatography, including：
A. the preparation of test sample：This product pharmaceutical composition 2mL is taken, adds ethanol 20mL, ultrasonic extraction 30 minutes, filters,
Water bath method, residue add methanol 1mL to make dissolving, take supernatant as need testing solution；
B. the preparation of control medicinal material solution：Ginkgo leaf control medicinal material 1g is taken, adds ethanol 20mL, heating and refluxing extraction 10min,
Filtration, water bath method, residue adds methanol 1mL to make dissolving, as control medicinal material solution；
C. ginkgo leaf indentification by TLC：According to thin-layered chromatography test, respectively draw ginkgo leaf control medicinal material solution and
Each 5 μ L of test sample, put respectively on same silica gel g thin-layer plate, using ethyl acetate-butanone-formic acid-water (5: 3: 1: 1) as
Solvent, deploy, take out, dry, spray：3% alchlor ethanol solution, hot blast drying, put and examined under ultraviolet lamp (365nm)
Depending on；
(3) content of anoectochilus roxburghii glycosides in high effective liquid chromatography for measuring medicine is used, including：
A. high-efficient liquid phase chromatogram condition：Inertsil ODS-3 chromatographic columns, octadecylsilane chemically bonded silica are filler,
Mobile phase is methanol A- formic acid waters, gradient elution is 0~10min 30%A → 35%A, 10~45min 35%A → 45%A,
45~60min 45%A → 75%A, equilibration time 15min, flow velocity 0.8mL/min, the μ L of sample size 10,24 DEG C of column temperature, PDA inspections
Survey device acquisition range：190~400nm；Detection wavelength 215nm；
B. the preparation of need testing solution：Take and repair the Chinese medicine preparation that skin barrier acts on, conventional ethanol soak extraction 24 is small
When, with filtered through gauze, it is concentrated under reduced pressure as the 2%-5% of original weight amount, macroporous resin adsorption on concentrate, 5%-95% ethanol is washed
It is de-, concentrate eluant, add methanol constant volume to i.e. every milliliter of decoction active compound containing 1g, with methanol dilution 5,10,15 times it is standby；
C. the preparation of reference substance solution：Precision weighs Hernandulcin, polygalic acid, camellianin A and anoectochilus roxburghii glycosides pair
According to each 2mg of product, respectively plus methanol prepares the reference substance solution of different multiples mass concentration；
D. linear relationship is investigated：The accurate reference substance solution for drawing above-mentioned various concentrations, high performance liquid chromatograph enter respectively
The μ L of sample 10, linear regression is carried out with the response signal and concentration that measure, obtains the regression equation of standard items；
E. determination method：It is accurate respectively to draw reference substance and each 10 μ L of need testing solution, inject hplc determination.
As preferable, repair the pharmaceutical composition of skin barrier clarification process and method of quality control test sample it is molten
Liquid is Aqueous extracts, and specific method is：The Chinese medicine preparation for repairing skin barrier effect is taken, conventional ethanol soak extraction 24 hours, is used
Filtered through gauze, it is concentrated under reduced pressure as the 2%-5% of original weight amount, macroporous resin adsorption on concentrate, 5%-95% ethanol elutions, concentration
Eluent, add methanol constant volume to i.e. every milliliter of decoction active compound containing 1g, with methanol dilution 5,10,15 times it is standby.
Preferably, the clarification process of the pharmaceutical composition of described reparation skin barrier and method of quality control are used to extract
Method identical medicinal composition tablets, granule or medicine composition pour containing radix cynanchi atrati, Pilea fasciata, ginkgo leaf, chrysanthemum
The compound of lotus, stone precipice tea and roxburgh anoectochilus terminal bud medicinal material.
Preferably, the clarification process of pharmaceutical composition of skin barrier and the assay side of method of quality control are being repaired
In method：Test sample dilutes 5 times, crosses 0.22 μm of filter membrane, 10 μ L enter liquid chromatograph, the content of anoectochilus roxburghii glycosides is：10.51μg/ml.
Preferably, described thin-layered chromatography differentiates in radix cynanchi atrati, ginkgo leaf, radix cynanchi atrati with n-butanol-ethyl acetate-water (4:
1: 5) be used as solvent, the colour developing of spray ethanol solution of sulfuric acid, ginkgo leaf using ethyl acetate-butanone-formic acid-water (5: 3: 1: 1) as
Solvent, spray：3% alchlor ethanol solution develops the color.
The present invention is with the identification composition Hernandulcin of Pilea fasciata medicinal material, the identification composition of false-yellowflower milkwort root or herb medicinal material
Polygalic acid, the identification composition camellianin A of stone precipice tea medicinal material, the composition anoectochilus roxburghii glycosides of identifying of roxburgh anoectochilus terminal bud medicinal material are index, the party
Method avoids medicine group and the overlapping of (peak) is responded under same chromatographic condition into medicinal material Chinese medicine thing composition, with containing for active component
Measurement is set to control standard, more rationally, truly reflects a kind of Traditional Chinese medicine composition for having and repairing skin barrier effect
Quality.
Figure of description
Fig. 1 is radix cynanchi atrati control medicinal material figure.
Fig. 2 is ginkgo leaf control medicinal material figure.
Fig. 3 is Hernandulcin under 215nm wavelength, polygalic acid, the chromatogram of camellianin A and anoectochilus roxburghii glycosides reference substance
Figure.
Fig. 4 is HPLC chromatogram under the pharmaceutical composition 215nm wavelength for repairing skin barrier.
Fig. 5 is placebo solution HPLC chromatogram under 215nm wavelength.
Embodiment
A kind of clarification process and method of quality control with the pharmaceutical composition for repairing skin barrier effect of the present invention, should
Clarification process is carried out as follows：
Clarification process and each component content
(1) preparation of fining agent：II type ZTC1+1 natural clarifying agents are by A, the components of B two composition.Component A：Precision measures
Added in 1.0g component As on a small quantity in distilled water, stir into pasty state, add the viscose that distilled water is formulated into 100mL, be swelled
24h, filtered and produced with double gauze.B component：Precision measures the acetic acid for adding that a small amount of volume fraction is 1% in 1.0g B components
Solution, pasty state is stirred into, then the acetum for adding volume fraction to be 1% is configured to 100mL viscose, 24h is swelled, with bilayer
Filtered through gauze, produce.
(2) fining agent A, B addition sequences：According to specification, ZTC natural clarifying agents mainly select according to the property of solution
Different orders of addition, general Chinese medicine compound prescription are sour environment relative to isoelectric points of proteins (pH=4.8), and order of addition is first
Component A after B, B component dosage are 2 times of component A.
(3) evaluation index：Hernandulcin contents retention rate (X1), polygalic acid content retention rate are chosen respectively
(X2), camellianin A content retention rate (X3), anoectochilus roxburghii glycosides content retention rate (X4), solid content clearance (X5) refer to as evaluation
Mark carries out comprehensive grading, compound retention rate weight is set into 0.7, solid content clearance X5 weights are set to 0.3, i.e. OD%=
(0.7X1+0.7X2+0.7X3+0.7X4)/4+0.3X5.Calculation formula is as follows：
Content × 100% of compound in content/extract solution of compound is extracted after compound retention rate=clarification
Solid content before solid content clearance=(solid content after solid content-clarification before clarification)/clarification ×
100%
(4) technique is investigated：It is investigation factor with fining agent addition, solid-liquid ratio, temperature, time, it is each to choose 3 optimal water
It is flat, with L9(34) orthogonal arrage tested, comprehensive grading is calculated with compound retention rate and solid content clearance, carries out variance point
Analysis, the results are shown in Table 2.Fining agent addition and extract solution solid-liquid ratio are commented synthesis it can be seen from the variance analysis of orthogonal test
Divide and have a significant impact, temperature and time is not statistically significant to the clarifying effect of extract solution.Found in experiment, fining agent B component
For 4% when the clear effect of pharmaceutical composition Aqueous extracts it is good, determine II type ZTC 1+1 natural clarifying agents clarify pharmaceutical composition extract solution
Optimum process condition be fining agent addition B component 4%, B component is that 2% solid-liquid ratio is 1: 5, and temperature is 60 DEG C, during reaction
Between 1h.
The L of table 29(34) orthogonal experiments
(5) each component content：With the optimised process bar of II type ZTC 1+1 natural clarifying agents clarification pharmaceutical composition extract solution
Part：Fining agent addition B component 4%, B component are that 2% solid-liquid ratio is 1: 5, and temperature is 60 DEG C, reaction time 1h, prepares sample.
High-efficient liquid phase chromatogram condition：Inertsil ODS-3 chromatographic columns, eluent gradient are shown in Table 1, equilibration time 15min, flow velocity
0.8mL/min, 24 DEG C of column temperature, PDA detector acquisition ranges：190~400nm；Detection wavelength 215nm, the μ L of sample introduction 10.Selection
215nm wavelength determines Hernandulcin, polygalic acid, camellianin A and anoectochilus roxburghii glycosides content respectively.Sample continuous acupuncture 3 times,
Average.Every gram of crude drug is measured by method of quality control of the present invention, the content of anoectochilus roxburghii glycosides is：10.51μg/ml.
As Figure 1-5, a kind of clarification process and matter with the pharmaceutical composition for repairing skin barrier effect of the present invention
Amount control method, the method for quality control are carried out as follows：
(1) preparation of need testing solution：Take and repair the Chinese medicine preparation that skin barrier acts on, conventional ethanol soak extraction 24 is small
When, with filtered through gauze, it is concentrated under reduced pressure as the 2%-5% of original weight amount, macroporous resin adsorption on concentrate, 5%-95% ethanol is washed
It is de-, concentrate eluant, add methanol constant volume to i.e. every milliliter of decoction active compound containing 1g, with methanol dilution 5,10,15 times it is standby；
(2) the preparation precision of reference substance solution weighs Hernandulcin, polygalic acid, camellianin A and anoectochilus roxburghii glycosides
2mg, respectively plus methanol prepares different multiples mass concentration reference substance solution.
(3) linear relationship is investigated：The accurate reference substance solution for drawing above-mentioned various concentrations, high performance liquid chromatograph enter respectively
The μ L of sample 10, linear regression is carried out with the response signal (peak area) and concentration that measure, obtains the regression equation of 5 kinds of standard items.
Hernandulcin Y=253.53X+42.37 (R2=0.9996), concentration is linearly good in 3.245~30.35g/mL scopes
It is good., polygalic acid Y=288.53X+34.05 (R2=0.9997), concentration is linearly good in 2.245~22.34g/mL scopes.,
Camellianin A Y=228.53X+38.48 (R2=0.9999), concentration is linearly good in 3.545~35.35g/mL scopes., gold
Line lotus glycosides Y=267.15 X+51.31 (R2=0.9995), concentration is linearly good in 4.245~42.35g/mL scopes.
(4) assay method：Determined according to high-efficient liquid phase chromatogram condition, chromatographic condition and system suitability and Inertsil
ODS-3 chromatographic columns, mobile phase are shown in Table 1, equilibration time 15min, flow velocity 0.8mL/min, the μ L of sample introduction 10,24 DEG C of column temperature, PDA detections
Device acquisition range：190~400nm；Detection wavelength 215nm.
The eluent gradient of table 1 elutes table
(5) efficiency evaluation is carried out to the assay method of above-mentioned determination, including precision, repeatability, stability etc..
2. radix cynanchi atrati, ginkgo leaf are differentiated with thin-layered chromatography in silver medal bits miraculous cure compositions：
(1) radix cynanchi atrati thin-layered chromatography differentiates
The preparation of test sample：This product pharmaceutical composition 2mL is taken, adds methanol 30mL, ultrasonic extraction 20 minutes, filters, filter
Liquid is evaporated, and residue adds methanol 1mL to make dissolving, as need testing solution；
The preparation of control medicinal material solution：Radix cynanchi atrati control medicinal material powder 1g is taken, adds methanol 30mL, ultrasonic extraction 20 minutes, filter
Cross, filtrate is evaporated, and residue adds methanol 1mL to make dissolving, as radix cynanchi atrati medicinal material solution；
Radix cynanchi atrati indentification by TLC：Tested according to thin-layered chromatography, draw control medicinal material solution and each 2 μ of sample solution respectively
L, put respectively on same silica gel g thin-layer plate, using n-butanol-ethyl acetate-water (4: 1: 5) as solvent, deploy, take out,
Dry, spray ethanol solution of sulfuric acid, it is clear to be heated to spot development at 105 DEG C, is inspected under white light；
(2) ginkgo leaf thin-layered chromatography differentiates
The preparation of test sample：This product pharmaceutical composition 2mL is taken, adds ethanol 20mL, ultrasonic extraction 30 minutes, filtration, water
Bath is evaporated, and residue adds methanol 1mL to make dissolving, takes supernatant as need testing solution；
The preparation of control medicinal material solution：Ginkgo leaf control medicinal material 1g is taken, adds ethanol 20mL, heating and refluxing extraction 10min, is filtered
Cross, water bath method, residue adds methanol 1mL to make dissolving, as control medicinal material solution；
Ginkgo leaf indentification by TLC：Tested according to thin-layered chromatography, draw ginkgo leaf control medicinal material solution and confession respectively
Each 5 μ L of test agent, put respectively on same silica gel g thin-layer plate, exhibition is used as using ethyl acetate-butanone-formic acid-water (5: 3: 1: 1)
Agent is opened, is deployed, takes out, dries, is sprayed：3% alchlor ethanol solution, hot blast drying, put and inspected under ultraviolet lamp (365nm)；
A kind of clarification process and method of quality control with the pharmaceutical composition for repairing skin barrier effect of the present invention, it is excellent
The preparation of the need testing solution of choosing：The preparation of this method publicity product solution：The Chinese medicine preparation for repairing skin barrier effect is taken, it is conventional
Ethanol soak extraction 24 hours, with filtered through gauze, it is concentrated under reduced pressure as the 2%-5% of original weight amount, macroreticular resin is inhaled on concentrate
It is attached, 5%-95% ethanol elutions, concentrate eluant, add methanol constant volume to i.e. every milliliter of decoction active compound containing 1g, with methanol dilution 5,
10th, 15 times it is standby；
The present invention is a kind of to be had in the clarification process and method of quality control for repairing the pharmaceutical composition that skin barrier acts on,
Preferable assay method：High-efficient liquid phase chromatogram condition determines, chromatographic condition and system suitability： Inertsil ODS-3
Chromatographic column, eluent gradient are shown in Table 1, equilibration time 15min, flow velocity 0.8mL/min, 24 DEG C of column temperature, PDA detectors collection model
Enclose：190~400nm；Detection wavelength 215nm, the μ L of sample introduction 10.
Method of quality control of the present invention, due to a length of 240nm of Hernandulcin maximum absorption wave, polygala soap
The a length of 202nm of maximum absorption wave of glycosides, a length of 215 nm of maximum absorption wave of camellianin A and anoectochilus roxburghii glycosides, therefore select 215nm ripples
It is long to determine anoectochilus roxburghii glycosides content respectively.
Present inventor is known through investigating, when using acetonitrile-water, acetonitrile-formic acid water, methanol-water solution is as flowing
Phase gradient elute when, drug ingedient separation it is undesirable, with methyl alcohol-formic acid aqueous systems elute, each composition of medicine do not have it is overlapping, and
Peak shape is excellent.Medicine group is evaluated and controlled on the whole to this experimental program by the quality control to active constituents of medicine content
Compound quality, more rationally, truly reflect a kind of quality for the Traditional Chinese medicine composition for repairing skin barrier.
Claims (6)
- A kind of 1. clarification process with the pharmaceutical composition for repairing skin barrier effect, it is characterised in that：Take and repair skin screen The Chinese medicine preparation conventional ethanol soak extraction of barrier effect, soak are concentrated under reduced pressure, and concentrate macroporous resin adsorption, use 5%- 95% ethanol elution, eluent concentration, it is the described pharmaceutical composition for repairing skin barrier effect, is placed in 60 DEG C of water Bath, the II type ZTC1+1 natural clarifying agent B components of 4% effluent volume are first added, the II types ZTC1+1 of 2% volume is added after 1h Natural clarifying agent component A, during which stirred per half an hour and make impurity component coagulative precipitation in 1 minute, then in centrifuge with 4000r/min centrifuges 10min, takes supernatant；Described II type ZTC1+1 natural clarifying agents：It is a kind of using natural polysaccharide as original Natural high molecular substance made of material, it is made up of two components of A, B, component A is yellowish-brown soluble solids powder or light brown Liquid, main amylase-containing, be made into 1% the aqueous solution use；B component is light yellow soluble solids powder or light brown liquid Body, the complex enzyme of main amylase-containing, the solution that 1% concentration is made into 1% acetic acid use.Component A, precision measure 1.0g II type ZTC1+1 natural clarifying agents and added on a small quantity in distilled water, stir into pasty state, add Distilled water is formulated into 100mL viscose, is swelled 24h, is filtered with double gauze；B component, precision measure 1.0g II type ZTC1+1 natural clarifying agents and add the acetum that a small amount of volume fraction is 1%, stir Pasty state is mixed, then the acetum for adding volume fraction to be 1% is configured to 100 mL viscose, 24h is swelled, with double gauze mistake Filter.
- A kind of 2. method of quality control with the pharmaceutical composition for repairing skin barrier effect, it is characterised in that this method bag Include following steps：(1) the medicine Chinese medicine radix cynanchi atrati is differentiated with thin-layered chromatography, including：A. the preparation of test sample：This product pharmaceutical composition 2mL is taken, adds methanol 30mL, ultrasonic extraction 20 minutes, filtration, filtrate It is evaporated, residue adds methanol 1mL to make dissolving, as need testing solution；B. the preparation of control medicinal material solution：Radix cynanchi atrati control medicinal material powder 1g is taken, adds methanol 30mL, ultrasonic extraction 20 minutes, filters, Filtrate is evaporated, and residue adds methanol 1mL to make dissolving, as radix cynanchi atrati medicinal material solution；C. radix cynanchi atrati indentification by TLC：Tested according to thin-layered chromatography, draw control medicinal material solution and each 2 μ L of sample solution respectively, Put respectively on same silica gel g thin-layer plate, using n-butanol-ethyl acetate-water (4: 1: 5) as solvent, deploy, take out, dry in the air It is dry, ethanol solution of sulfuric acid is sprayed, it is clear to be heated to spot development at 105 DEG C, is inspected under white light；(2) the medicine Chinese medicine ginkgo leaf is differentiated with thin-layered chromatography, including：A. the preparation of test sample：This product pharmaceutical composition 2mL is taken, adds ethanol 20mL, ultrasonic extraction 30 minutes, filtration, water-bath It is evaporated, residue adds methanol 1mL to make dissolving, takes supernatant as need testing solution；B. the preparation of control medicinal material solution：Ginkgo leaf control medicinal material 1g is taken, adds ethanol 20mL, heating and refluxing extraction 10min, is filtered Cross, water bath method, residue adds methanol 1mL to make dissolving, as control medicinal material solution；C. ginkgo leaf indentification by TLC：Tested according to thin-layered chromatography, draw ginkgo leaf control medicinal material solution respectively and for examination Each 5 μ L of sample, put respectively on same silica gel g thin-layer plate, expansion is used as using ethyl acetate-butanone-formic acid-water (5: 3: 1: 1) Agent, deploy, take out, dry, spray：3% alchlor ethanol solution, hot blast drying, put and inspected under ultraviolet lamp (365nm)；(3) Hernandulcin in high effective liquid chromatography for measuring medicine, polygalic acid are used, camellianin A and anoectochilus roxburghii glycosides contain Amount, including：A. high-efficient liquid phase chromatogram condition：Inertsil ODS-3 chromatographic columns, octadecylsilane chemically bonded silica are filler, flowing Be mutually methanol A- formic acid waters, gradient elution is 0~10min 30%A → 35%A, 10~45min 35%A → 45%A, 45~ 60min 45%A → 75%A, equilibration time 15min, flow velocity 0.8mL/min, the μ L of sample size 10,24 DEG C of column temperature, PDA detectors Acquisition range：190~400nm；Detection wavelength 215nm；B. the preparation of need testing solution：The Chinese medicine preparation for repairing skin barrier is taken, conventional ethanol soak extraction 24 hours, uses gauze Filtering, it is concentrated under reduced pressure as the 2%-5% of original weight amount, macroporous resin adsorption on concentrate, 5%-95% ethanol elutions, concentration elution Liquid, add methanol constant volume to i.e. every milliliter of decoction active compound containing 1g, with methanol dilution 5,10,15 times it is standby；C. the preparation of reference substance solution：Precision weighs Hernandulcin, polygalic acid, camellianin A and anoectochilus roxburghii glycosides reference substance Each 2mg, respectively plus methanol prepares the reference substance solution of different multiples mass concentration；D. linear relationship is investigated：The accurate reference substance solution for drawing above-mentioned various concentrations respectively, the μ of high performance liquid chromatograph sample introduction 10 L, linear regression is carried out with the response signal and concentration that measure, obtains the regression equation of standard items；E. determination method：It is accurate respectively to draw reference substance and each 10 μ L of need testing solution, inject hplc determination.
- 3. according to claim 1, a kind of clarification process and matter with the pharmaceutical composition for repairing skin barrier effect described in 2 Amount control method, this method need testing solution are alcohol extract, and specific method is：The Chinese medicine preparation for repairing skin barrier is taken, it is conventional Ethanol soak extraction 24 hours, with filtered through gauze, it is concentrated under reduced pressure as the 2%-5% of original weight amount, macroporous resin adsorption on concentrate, 5%-95% ethanol elutions, concentrate eluant, add methanol constant volume to i.e. every milliliter of decoction active compound containing 1g, with methanol dilution 5,10, 15 times standby.
- 4. according to claim 1, a kind of clarification process and matter with the pharmaceutical composition for repairing skin barrier effect described in 2 Amount control method, it is characterised in that：This method is used for extracting method identical medicinal composition tablets, granule or medicine composition Compound containing radix cynanchi atrati, Pilea fasciata, ginkgo leaf, false-yellowflower milkwort root or herb, stone precipice tea and roxburgh anoectochilus terminal bud medicinal material.
- 5. according to claim 1, a kind of clarification process and matter with the pharmaceutical composition for repairing skin barrier effect described in 2 Amount control method, it is characterised in that in content assaying method：Test sample dilutes 5 times, crosses 0.22 μm of filter membrane, and 10 μ L enter liquid phase color Spectrometer, the content of anoectochilus roxburghii glycosides are：10.50μg/ml.
- 6. according to claim 1, a kind of clarification process and matter with the pharmaceutical composition for repairing skin barrier effect described in 2 Amount control method, it is characterised in that：Described thin-layered chromatography differentiates in radix cynanchi atrati, ginkgo leaf that radix cynanchi atrati is with n-butanol-acetic acid second Ester-water (4: 1: 5) is used as solvent, and the colour developing of spray ethanol solution of sulfuric acid, ginkgo leaf are with ethyl acetate-butanone-formic acid-water (5: 3: 1 : solvent 1) is used as, is sprayed：3% alchlor ethanol solution develops the color.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710885659.3A CN107865944A (en) | 2017-09-19 | 2017-09-19 | A kind of clarification process and method of quality control with the pharmaceutical composition for repairing skin barrier effect |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710885659.3A CN107865944A (en) | 2017-09-19 | 2017-09-19 | A kind of clarification process and method of quality control with the pharmaceutical composition for repairing skin barrier effect |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107865944A true CN107865944A (en) | 2018-04-03 |
Family
ID=61753135
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710885659.3A Pending CN107865944A (en) | 2017-09-19 | 2017-09-19 | A kind of clarification process and method of quality control with the pharmaceutical composition for repairing skin barrier effect |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107865944A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110082470A (en) * | 2019-05-09 | 2019-08-02 | 四川逢春制药有限公司 | A kind of detection method of Santanning syrup |
| CN110082471A (en) * | 2019-05-09 | 2019-08-02 | 四川逢春制药有限公司 | A kind of detection method of Jiegeng Donghua Tableties |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105891404A (en) * | 2015-01-18 | 2016-08-24 | 广东省中医院 | Quality control method for traditional Chinese medicine oral liquid for treating psoriasis |
| CN105879432A (en) * | 2015-01-18 | 2016-08-24 | 广东省中医院 | Method for clarifying Chinese herbal preparation for treating psoriasis |
| CN106728898A (en) * | 2016-12-14 | 2017-05-31 | 广州青岚生物科技有限公司 | A kind of pharmaceutical composition for repairing skin barrier and preparation method thereof |
-
2017
- 2017-09-19 CN CN201710885659.3A patent/CN107865944A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105891404A (en) * | 2015-01-18 | 2016-08-24 | 广东省中医院 | Quality control method for traditional Chinese medicine oral liquid for treating psoriasis |
| CN105879432A (en) * | 2015-01-18 | 2016-08-24 | 广东省中医院 | Method for clarifying Chinese herbal preparation for treating psoriasis |
| CN106728898A (en) * | 2016-12-14 | 2017-05-31 | 广州青岚生物科技有限公司 | A kind of pharmaceutical composition for repairing skin barrier and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 国家药典委员会: "《中华人民共和国药典：2015年版.一部》", 30 June 2015, 中国医药科技出版社 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110082470A (en) * | 2019-05-09 | 2019-08-02 | 四川逢春制药有限公司 | A kind of detection method of Santanning syrup |
| CN110082471A (en) * | 2019-05-09 | 2019-08-02 | 四川逢春制药有限公司 | A kind of detection method of Jiegeng Donghua Tableties |
| CN110082470B (en) * | 2019-05-09 | 2021-03-16 | 四川逢春制药有限公司 | Detection method of san Tan Ning syrup |
| CN110082471B (en) * | 2019-05-09 | 2021-04-27 | 四川逢春制药有限公司 | Detection method of platycodon grandiflorum and winter flower tablets |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mohapatra et al. | Influence of extraction methods and solvent system on the chemical composition and antioxidant activity of Centella asiatica L. leaves | |
| CN101336987B (en) | Preparation method of total flavone of Hovenia dulcisThunb | |
| Zhao et al. | Spectrum–effect relationships between high-performance liquid chromatography fingerprints and anti-inflammatory activities of Leontopodium leontopodioides (Willd.) Beauv. | |
| Zhang et al. | Pharmacokinetics difference of multiple active constituents from decoction and maceration of Fuzi Xiexin Tang after oral administration in rat by UPLC–MS/MS | |
| CN110196290A (en) | Ellagic acid content assaying method in a kind of Rosa roxburghii Tratt | |
| Wen et al. | Optimization of ultrasonic assisted extraction and biological activity of total flavonoids from Ligusticum chuanxiong Hort. using response surface methodology | |
| Hasan et al. | Phytochemical investigation and evaluation of antioxidant activity of fruit of Solanum indicum Linn | |
| CN107648369A (en) | A kind of clarification process and method of quality control of the pharmaceutical composition that there is treatment acne to act on | |
| CN107865944A (en) | A kind of clarification process and method of quality control with the pharmaceutical composition for repairing skin barrier effect | |
| CN105486766A (en) | Method for determining content of three antioxidation active compositions in honeysuckle flower and plant thereof by employing HPLC | |
| CN102841160B (en) | Quality control method of Sijunzi (Chinese name) decoction | |
| CN115825260A (en) | Construction method and detection method of characteristic map of Gujingcao formula granules | |
| CN109223904B (en) | Kidney tonifying and blood circulation promoting formula and preparation method thereof | |
| CN1327217C (en) | Quality control of Jianweixiaoshi tablets for promotnig digest | |
| CN107669751A (en) | A kind of clarification process and method of quality control of the pharmaceutical composition that there is treatment red blood trace on face to act on | |
| CN107693696A (en) | A kind of clarification process and method of quality control with the drug extract for dispelling facial acne print effect | |
| CN114755361B (en) | Quality detection method of traditional Chinese medicine compound composition for treating allergic rhinitis of children | |
| CN114755328A (en) | A method for constructing high-performance liquid phase characteristic map of Evodia salt and its application | |
| Dashora et al. | Antioxidant Activities of Dendrophthoe falcata (Lf) Etting | |
| CN108030813A (en) | A kind of clarification process and method of quality control of the pharmaceutical composition with delay skin aging | |
| CN113203808A (en) | Detection method of fire therapy liniment | |
| CN107014945B (en) | A kind of detection method of Chinese medicine preparation that treating acute infectious hepatitis | |
| CN107865927A (en) | A kind of clarification process and method of quality control of the pharmaceutical composition that there are treatment livid ring around eye to act on | |
| CN107441343A (en) | A kind of clarification process and method of quality control of the pharmaceutical composition with the effect of therapeutic sensitivity skin | |
| Bolem et al. | Phytochemical Composition and Antidiabetic Potential of Gymnema sylvestre Extracts and Formulations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180403 |
|
| WD01 | Invention patent application deemed withdrawn after publication |